XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Jun. 30, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 3,638 $ 9,007
Short-term bank deposits 26,130 31,449
Restricted cash and restricted short-term deposits 3,716 316
Marketable securities 30,349 13,441
Other current assets 876 872
Total current assets 64,709 55,085
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 316 421
Severance pay fund 1,220 905
Property and equipment, net 11,125 11,866
Other long term assets 18 39
Total long-term assets 12,679 13,231
Total assets 77,388 68,316
CURRENT LIABILITIES    
Trade payables 2,696 2,837
Accrued expenses 1,155 1,040
Deferred revenues 379 379
Advance payment from United Therapeutics 261 393
Other accounts payable 1,951 1,272
Total current liabilities 6,442 5,921
LONG-TERM LIABILITIES    
Deferred revenues 2,941 3,226
Accrued severance pay 1,436 1,023
Other long-term liabilities 611 680
Total long-term liabilities 4,988 4,929
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 67,849,535 shares as of March 31, 2014, 59,196,617 shares as of June 30, 2013    [1]    [1]
Additional paid-in capital 170,721 144,109
Accumulated deficit (107,638) (86,902)
Other comprehensive income 2,875 259
Total stockholders' equity 65,958 57,466
Total liabilities and stockholders' equity $ 77,388 $ 68,316
[1] Less than $1